Somni Capital

Somni Capital is a New York-based venture firm with a single specialized thesis: backing early-stage technologies and consumer devices focused on sleep science. The investment focus spans wellness and consumer health alongside medical devices, but the unifying thread is a deliberate concentration on sleep as a category, including diagnostic, therapeutic, and consumer-facing products. The narrowness is the firm’s defining feature; rather than treating sleep as one vertical among many, Somni Capital builds its entire investment posture around it, which gives the team uncommon depth in sleep science, clinical research, and the consumer dynamics of the category. Limited public information is available about specific named partners and a fully disclosed portfolio in this profile, but the thematic specialization is the firm’s clear identity.

Check sizes typically run from two hundred fifty thousand to one million dollars, deployed at seed and Series A. Geographic focus is the United States, with the firm engaging primarily with companies operating in or expanding into U.S. sleep markets. The check size positions Somni Capital as a meaningful early backer rather than a lead in larger institutional rounds.

For founders, Somni Capital is a natural conversation when sleep is the explicit center of the business, whether through devices, software, therapeutics, or consumer products. Expect a partner that brings genuine sleep science fluency and a willingness to engage on both the clinical and commercial realities of the category. Founders working in adjacent wellness areas without a clear sleep focus will find the fit weaker. The strongest match is a company that benefits from a thematically specialized investor who has thought deeply about how sleep maps to product, clinical evidence, and consumer adoption.